Johnson and Johnson reported 4th-quarter earnings Wednesday and signs show the company may be regaining its health. WSJheard explains. WSJWhatsNow
Fourth-quarter results were solid, although unspectacular. Sales of $20.7 billion narrowly missed analyst expectations, while adjusted earnings of $1.
88 a share topped estimates. Shares edged lower in morning trading after rallying sharply since November. But there is good reason to expect the selloff to be brief.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
J&J forecasts weak annual profit, misses revenue estimatesJohnson & Johnson on Wednesday forecast full-year profit largely below expectati...
Weiterlesen »
Magic Johnson Gets Emotional at David Stern Memorial, 'I'll Miss My Angel''I'm going to miss my angel,' an emotional Johnson told the crowd.
Weiterlesen »
Starbucks aims to become 'resource positive' in climate pushStarbucks CEO Kevin Johnson announced Tuesday that the coffee chain will strive to become 'resource positive.'
Weiterlesen »
UK PM Johnson defeated on Brexit legislation for first time since electionBritish Prime Minister Boris Johnson's government was defeated in parliamen...
Weiterlesen »
Johnson defeated on Brexit legislation for first time since electionBritish Prime Minister Boris Johnson's government was defeated in parliamen...
Weiterlesen »
Johnson & Johnson’s Profit, Sales RiseJohnson & Johnson had sales increases in its pharmaceuticals and consumer-products divisions but a slight decline in its medical-devices business
Weiterlesen »